Dr. Osei-Boateng is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
447 McAlister Rd
Ste 1600
Lincolnton, NC 28092Phone+1 980-212-5100Fax+1 980-212-1014
Education & Training
- Cleveland Clinic FoundationFellowship, Hematology and Medical Oncology, 2010 - 2013
- University of MarylandResidency, Internal Medicine, 1998 - 2001
- University of Michigan Medical SchoolClass of 1998
Certifications & Licensure
- NC State Medical License 2013 - 2026
- OH State Medical License 2010 - 2014
- MD State Medical License 2001 - 2011
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Enzalutamide and Docetaxel in Combination With Androgen Deprivation for Men With Metastatic Hormone-Sensitive Prostate Cancer: ENZADA, a Phase II Trial.Earle F Burgess, Claud M Grigg, Danielle Boselli, James T Symanowski, AliReza Golshayan
Clinical Genitourinary Cancer. 2025-01-08 - 2 citationsReal-World Impact of an In-House Dihydropyrimidine Dehydrogenase () Genotype Test on Fluoropyrimidine Dosing, Toxicities, and Hospitalizations at a Multisite Cancer Ce...D Grace Nguyen, Sarah A Morris, Alicia Hamilton, Simeon O Kwange, Nury Steuerwald
JCO Precision Oncology. 2024-06-01 - 6 citationsPertuzumab Plus Trastuzumab in Patients With Lung Cancer WithMutation or Amplification: Results From the Targeted Agent and Profiling Utilization Registry Study.Apar K Ganti, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Elie G Dib
JCO Precision Oncology. 2023-06-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: